03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Xalkori 200mg° : | |
Type | Medicine Withdrawn |
Originator | B |
Agent | Droguerie Fattal |
Distributor | Droguerie Fattal |
Laboratory | Pfizer |
Manufacturer | Pfizer Pharmaceutical LLC |
Origin | U.S.A. |
ATC | L01XE16 |
Xalkori 200mg° :
Xalkori 200mg° :
Xalkori 200mg° :
Xalkori 200mg° :
Xalkori 200mg° :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Xalkori 200mg° :
Xalkori 200mg° :
Xalkori 200mg° :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Acute respiratory distress syndrome | Not known |
ALT increased | Not known |
Anaemia | Very Common |
AST increased | Not known |
Balance disorder | Not known |
Blood alkaline phosphatase increased | Common |
Blood bilirubin increased | Not known |
Bradycardia | Common |
Constipation | Very Common |
Decreased appetite | Very Common |
Diarrhoea (Diarrhea) | Very Common |
Diplopia | Not known |
Dizziness | Very Common |
Drug-induced liver injury | Not known |
Dysaesthesia | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Very Common |
Dyspepsia | Common |
ECG QT prolonged | Common |
Face oedema | Not known |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Not known |
Gait disturbance | Not known |
Gamma-GT increased | Not known |
Gastrointestinal perforation | Uncommon |
Generalized oedema | Not known |
Haemoglobin decreased | Not known |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Uncommon |
Hepatic function abnormal | Not known |
Hypoesthesia | Not known |
Hypophosphataemia | Common |
Interstitial pneumonitis | Common |
Leucopenia (Leukopenia) | Common |
Local swelling | Not known |
Localised oedema | Not known |
Muscle weakness | Not known |
Nausea | Very Common |
Neuralgia | Not known |
Neuropathy peripheral | Very Common |
Neutropenia | Very Common |
Neutrophil count decreased | Not known |
Oedema | Very Common |
Oedema peripheral | Not known |
Orthostatic dizziness | Not known |
Paraesthesia (paresthesia) | Not known |
Periorbital oedema | Not known |
Peripheral sensory neuropathy | Not known |
Photophobia | Not known |
Photopsia | Not known |
Pneumonitis | Not known |
Polyneuropathy | Not known |
Renal cyst | Common |
Sinus bradycardia | Not known |
Skin burning sensation | Not known |
Skin rash | Common |
Syncope | Common |
Transaminases increased | Very Common |
Vision blurred | Not known |
Visual acuity reduced | Not known |
Visual disturbance | Very Common |
Vitreous floaters | Not known |
Vomiting | Very Common |
Xalkori 200mg° :
NB : Products With Same Indication |
Different Units By MoH Code
Xalkori 200mg° MoH 7299 :
Form | Capsule, hard |
Package Size | Box of 60 |
Strength | 200mg |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✔ |
Reg. Number | 186274/13 |
Submission date | 01/01/2013 |
Registration Year | 2014 |
Withdrawn Date | 2019 |
Price Comparison
● Country: | Ireland | |
● Package Size: | 60 | |
● Public Price: | 5002.72 EUR | ( 484,643,502.72 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 83,3787 EUR | ( 8,040,708.00 LBP ) |
● Pricing Date: | 08/10/2020 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 60 | |
● Public Price: | 4411.54 EUR | ( 427,372,349.04 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 73,5257 EUR | ( 7,071,948.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Egypt | |
● Package Size: | 60 | |
● Public Price: | 39384 EGP | ( 71,875,800.00 LBP ) |
● Pack size unit used: | 60 | |
● Cost/Unit: | 656,4 EGP | ( 1,197,200.00 LBP ) |
● Pricing Date: | 20/11/2019 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File